Potential use of the PARP inhibitor rucaparib to enhance cervical cancer treatment
Saha, S., Howarth, R., Pappworth, I., Marchbank, K. and Curtin, N. 2020. Potential use of the PARP inhibitor rucaparib to enhance cervical cancer treatment. European Journal of Cancer. 138 (Supp 2), p. S37. https://doi.org/10.1016/s0959-8049(20)31169-2